Price Alert

Co-Diagnostics Inc. (CODX)

NASDAQ: CODX · Real-Time Price · USD

0.30

-0.00 (-0.03%)

At close: Jun 09, 2025, 3:59 PM

-0.03% (1D)

Bid	0.26
Market Cap	10.11M
Revenue (ttm)	1M
Net Income (ttm)	-35.86M
EPS (ttm)	-1.17
PE Ratio (ttm)	-0.26
Forward PE	-0.73
Analyst	n/a

Ask	0.32
Volume	435,320
Avg. Volume (20D)	357,788
Open	0.28
Previous Close	0.30
Day's Range	0.28 - 0.31
52-Week Range	0.23 - 2.23
Beta	0.58

About CODX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CODX

Website n/a

Full Company Profile

Why Price Moved

11 months ago

+7.2%

Co-Diagnostics shares are trading higher after the... Unlock content with Pro Subscription

1 year ago

+12.9%

Co-Diagnostics shares are trading higher after the CDC announced free at home Covid 19 test delivery programs will reopen in late September.

News

3 months ago · seekingalpha.com

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Br...

3 months ago · zacks.com

Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.31 per share a year ago.

4 months ago · zacks.com

All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy

CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 months ago · zacks.com

Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.50 per share a year ago.

5 months ago · seekingalpha.com

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Andrew Benson - IR Dwight Egan - CEO Brian Brown - CFO Conference Call Participants ...